Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariangela Greco

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Immunology|May 18, 2018
Insights into Mutation Effect in Three Poikiloderma with Neutropenia Patients by Transcript Analysis and Disease Evolution of Reported Patients with the Same Pathogenic VariantsElisa A Colombo, Nursel H Elcioglu, Claudio Graziano, et al.
Chemico-Biological Interactions|October 31, 2009
Epigenetic changes in therapy-related MDS/AMLMaria Teresa Voso, Francesco D'Alò, Mariangela Greco, et al.
Hematological Oncology|March 31, 2012
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosisMariangela Greco, Daniela Capello, Alessio Bruscaggin, et al.
Leukemia Research|November 26, 2008
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromesEmiliano Fabiani, Francesco D'Alò, Alessandra Scardocci, et al.
Blood Cells, Molecules & Diseases|July 27, 2010
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasmsMariangela Greco, Francesco D'Alò, Alessandra Scardocci, et al.
British Journal of Haematology|May 11, 2012
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndromeDavide Rossi, Silvia Rasi, Valeria Spina, et al.
Leukemia & Lymphoma|October 9, 2012
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemiaLorenzo De Paoli, Michaela Cerri, Sara Monti, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
The Journal of Experimental Medicine|August 15, 2012
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentDavide Rossi, Vladimir Trifonov, Marco Fangazio, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Immunology|May 18, 2018
Insights into Mutation Effect in Three Poikiloderma with Neutropenia Patients by Transcript Analysis and Disease Evolution of Reported Patients with the Same Pathogenic VariantsElisa A Colombo, Nursel H Elcioglu, Claudio Graziano, et al.
Chemico-Biological Interactions|October 31, 2009
Epigenetic changes in therapy-related MDS/AMLMaria Teresa Voso, Francesco D'Alò, Mariangela Greco, et al.
Hematological Oncology|March 31, 2012
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosisMariangela Greco, Daniela Capello, Alessio Bruscaggin, et al.
Leukemia Research|November 26, 2008
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromesEmiliano Fabiani, Francesco D'Alò, Alessandra Scardocci, et al.
Blood Cells, Molecules & Diseases|July 27, 2010
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasmsMariangela Greco, Francesco D'Alò, Alessandra Scardocci, et al.
British Journal of Haematology|May 11, 2012
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndromeDavide Rossi, Silvia Rasi, Valeria Spina, et al.
Leukemia & Lymphoma|October 9, 2012
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemiaLorenzo De Paoli, Michaela Cerri, Sara Monti, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
The Journal of Experimental Medicine|August 15, 2012
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentDavide Rossi, Vladimir Trifonov, Marco Fangazio, et al.
Pageof 2